Cancer metabolism is rewired to support cell survival in response to intrinsic and environmental
stressors. Identification of strategies to target these adaptions is an area of active …

Microbial dysbiosis is a colorectal cancer (CRC) hallmark and contributes to inflammation,
tumor growth, and therapy response. Gut microbes signal via metabolites, but how the …

Hypoxia is a hallmark of solid tumors that promotes cell growth, survival, and metastasis and
confers resistance to chemo and radiotherapies. Hypoxic responses are largely mediated …

Glioblastomas display hierarchies with self-renewing cancer stem-like cells (CSCs). RNA
sequencing and enhancer mapping revealed regulatory programs unique to CSCs causing …

Iron is a central micronutrient needed by all living organisms. Competition for iron in the
intestinal tract is essential for the maintenance of indigenous microbial populations and for host …

Iron-related disorders are among the most prevalent diseases worldwide. Systemic iron
homeostasis requires hepcidin, a liver-derived hormone that controls iron mobilization through …

Autophagy and iron metabolism are metabolic dependencies in PDAC. However, targeted
therapies for these pathways are lacking. We identify NCOA4-mediated selective autophagy …

Effective therapies are lacking for patients with advanced colorectal cancer (CRC). The CRC
tumor microenvironment has elevated metabolic waste products due to altered metabolism …

Microfold cells (M-cells) are specialized cells of the intestine that sample luminal microbiota
and dietary antigens to educate the immune cells of the intestinal lymphoid follicles. The …

Systemic iron homeostasis needs to be tightly controlled, as both deficiency and excess iron
cause major global health concerns, such as iron deficiency anemia, hemochromatosis, etc. …